Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$517M |
| 2 |
NXP Semiconductors
NXPI
|
+$351M |
| 3 |
Oracle
ORCL
|
+$279M |
| 4 |
Palo Alto Networks
PANW
|
+$268M |
| 5 |
Boston Scientific
BSX
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$517M |
| 2 |
ExxonMobil
XOM
|
+$385M |
| 3 |
Cenovus Energy
CVE
|
+$292M |
| 4 |
PLAN
Anaplan, Inc.
PLAN
|
+$236M |
| 5 |
Phillips 66
PSX
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.01% |
| 2 | Technology | 7.76% |
| 3 | Financials | 7.66% |
| 4 | Healthcare | 7.12% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4801
Zoom
ZM
$28.7B
| $562K | ﹤0.01% |
5,207
-698,284
| -99% | -$73.6M |
|
4802
Merchants Bancorp
MBIN
$2.45B
| $561K | ﹤0.01% |
24,748
+15,236
| +160% | +$372K |
|
|
PFC
4803
DELISTED
Premier Financial Corp. Common Stock
PFC
| $561K | ﹤0.01% |
22,131
-67,534
| -75% | -$1.82M |
|
|
RPTX
4804
CALL
DELISTED
Repare Therapeutics
RPTX
| $560K | ﹤0.01% |
+40,000
| New | +$471K |
|
4805
Byline Bancorp
BY
$1.73B
| $559K | ﹤0.01% |
23,481
-34,493
| -59% | -$834K |
|
4806
Hubbell
HUBB
$24.3B
| $559K | ﹤0.01% |
3,132
-282,531
| -99% | -$53.2M |
|
4807
CALL
Heron Therapeutics
HRTX
$62M
| $558K | ﹤0.01% |
+200,000
| New | +$803K |
|
4808
Universal Corp
UVV
$1.14B
| $557K | ﹤0.01% |
9,205
-12,992
| -59% | -$775K |
|
4809
CuriosityStream
CURI
$155M
| $556K | ﹤0.01% |
+328,971
| New | +$664K |
|
|
COOLU
4810
DELISTED
Corner Growth Acquisition Corp. Unit
COOLU
| $556K | ﹤0.01% |
56,285
| – | – |
|
|
ASCBU
4811
DELISTED
A SPAC II Acquisition Corp. Unit
ASCBU
| $555K | ﹤0.01% |
+55,500
| New | +$553K |
|
4812
Scholastic
SCHL
$735M
| $553K | ﹤0.01% |
15,374
+7,343
| +91% | +$271K |
|
4813
Ero Copper
ERO
$4.05B
| $552K | ﹤0.01% |
65,406
-97,206
| -60% | -$1.21M |
|
|
TRON
4814
DELISTED
Corner Growth Acquisition Corp. 2 Class A Ordinary Share
TRON
| $550K | ﹤0.01% |
54,687
-164,061
| -75% | -$1.64M |
|
4815
Charles River Laboratories
CRL
$13.9B
| $549K | ﹤0.01% |
2,568
-229,111
| -99% | -$56M |
|
4816
PDS Biotechnology
PDSB
$11.8M
| $549K | ﹤0.01% |
+150,497
| New | +$715K |
|
4817
CALL
AdaptHealth
AHCO
$772M
| $548K | ﹤0.01% |
+30,400
| New | +$494K |
|
4818
Dare Bioscience
DARE
$14.2M
| $547K | ﹤0.01% |
37,091
+15,758
| +74% | +$237K |
|
4819
Electromed
ELMD
$248M
| $547K | ﹤0.01% |
56,736
-5,210
| -8% | -$61.6K |
|
4820
Caleres
CAL
$419M
| $546K | ﹤0.01% |
20,804
-391,885
| -95% | -$9.7M |
|
4821
Claros Mortgage Trust
CMTG
$229M
| $546K | ﹤0.01% |
32,570
-457,742
| -93% | -$8.64M |
|
4822
PUT
Sutro Biopharma
STRO
$339M
| $545K | ﹤0.01% |
+10,460
| New | +$584K |
|
|
TDCX
4823
DELISTED
TDCX Inc. American Depositary Shares, each representing one Class A ordinary share
TDCX
| $545K | ﹤0.01% |
58,948
-173,640
| -75% | -$2M |
|
|
IVAC
4824
DELISTED
Intevac Inc
IVAC
| $544K | ﹤0.01% |
112,464
+3,902
| +4% | +$19.9K |
|
4825
CALL
Intellia Therapeutics
NTLA
$1.8B
| $543K | ﹤0.01% |
+10,500
| New | +$533K |
|
Similar funds
Israel Englander's Q2 2022 Portfolio in Review
As of Q2 2022, Israel Englander held 7,971 positions worth $161B, down 15% from $189B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Israel Englander deployed $8.78B of net new capital in Q2 2022, opening 1,144 new positions and adding to 2,588 existing holdings. Its largest new stake was M&T Bank: 828,809 shares worth $132M.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, down from 60% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was ExxonMobil, an estimated $385M trimmed.
- Israel Englander's largest Q2 2022 buy was M&T Bank: 828,809 shares worth $132M.
- Israel Englander added most to Invesco QQQ Trust in Q2 2022, an estimated $517M increase.
- Israel Englander's biggest Q2 2022 reduction was ExxonMobil, cutting an estimated $385M.
- Israel Englander fully exited Cerner Corp in Q2 2022, selling an estimated $517M.
- Israel Englander's ten largest holdings make up 23% of its $161B portfolio in Q2 2022.
- Israel Englander opened 1,144 new positions and closed 1,065 in Q2 2022.
- Israel Englander's portfolio value fell 15% quarter-over-quarter to $161B.
Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.